keyword
https://read.qxmd.com/read/38719722/effect-of-intravenous-immunoglobulin-on-the-management-of-rh-and-abo-mediated-hemolytic-disease-of-the-newborn
#1
JOURNAL ARTICLE
Seyedeh Zohreh Jalali, Sadroddin Mahdipour, Roya Asgarzad, Farshid Saadat
BACKGROUND: Regarding the close association between neonatal hyperbilirubinemia and occurrence of pathological jaundice as a cause of neurotoxicity and kernicterus, the present study aimed to evaluate the use of intravenous immunoglobulin (IVIG) in neonates with hyperbilirubinemia. METHODS: A retrospective case-control study of blood group O mothers and their ABO and Rh newborns was conducted. Medical records that included total serum bilirubin levels of 79 patients with hemolytic disease of the newborn (HDN) from between 2017 and 2020 were reviewed...
April 18, 2024: Hematology, Transfusion and Cell Therapy
https://read.qxmd.com/read/38700687/contemporary-management-of-pediatric-brainstem-tumors
#2
REVIEW
Sheng-Che Chou, Yu-Ning Chen, Hsin-Yi Huang, Meng-Fai Kuo, Tai-Tong Wong, Sung-Hsin Kuo, Shih-Hung Yang
Brain tumors are the second most common malignancy in childhood. Around 15-20% of pediatric brain tumors occur in the brainstem. The most common type of brainstem tumor are diffuse tumors in the ventral pons, whereas focal tumors tend to arise from the midbrain, medulla, and dorsal pons. Glioma is the most common pathological entity. Contemporary management consists of surgery, radiotherapy, chemotherapy, and other adjuvant treatment. Surgical options range from biopsy to radical excision. Biopsy can be performed for diagnostic and prognostic purposes, or in the setting of clinical trials, mainly for diffuse intrinsic pontine gliomas...
2024: Advances and Technical Standards in Neurosurgery
https://read.qxmd.com/read/38682561/an-updated-review-on-the-safety-of-n-n-diethyl-meta-toluamide-insect-repellent-use-in-children-and-the-efficacy-of-natural-alternatives
#3
REVIEW
Helana Ghali, Sharon E Albers
N, N-diethyl-meta-toluamide (DEET) has been considered the 'gold standard' for insect repellent use since the 1950s and constitutes most insect repellents on the market. However, conflicting data in the scientific literature and confusing information in the media are at the core of debates about the safety of DEET insect repellents for the protection of children against arthropod bites. The few fatal occurrences involving DEET insect repellents and complications of their use in the pediatric population are typically the result of accidental overdoses or misuse of insect repellents that disregard warnings on product labels...
January 19, 2024: Pediatric Dermatology
https://read.qxmd.com/read/38680001/efficacy-and-toxicity-of-vincristine-and-cyp3a5-genetic-polymorphism-in-rhabdomyosarcoma-pediatric-egyptian-patients
#4
JOURNAL ARTICLE
Norhan Shalaby, Hala F Zaki, Osama A Badary, Sherif Kamal, Mohamed Nagy, Dalia Makhlouf, Amr Elnashar, Enas Elnadi, Sameh A Abdelshafi, Sherif Abouelnaga, Mona M Saber
BACKGROUND: Rhabdomyosarcoma (RMS) is a rare cancer that develops in soft tissue, particularly skeletal muscle tissue and occasionally hollow organs like the bladder or uterus. Vincristine (VCR) is the main therapy used in treatment of RMS, it is an alkaloid produced from vinca and it is one of the most commonly prescribed drugs in pediatric oncology for the treatment of a number of tumors. The CYP3A5 enzyme is responsible for vincristine metabolism. The effect of CYP3A5 genetic polymorphism on the efficacy and toxicity of VCR on RMS patients still needs further research...
April 1, 2024: Asian Pacific Journal of Cancer Prevention: APJCP
https://read.qxmd.com/read/38669002/car-t-cell-therapy-a-potential-treatment-strategy-for-pediatric-midline-gliomas
#5
REVIEW
Anand Kumar Das, Mainak Sinha, Saraj Kumar Singh, Anurag Chaudhary, Ashim Kumar Boro, Manish Agrawal, Sona Bhardwaj, Simmi Kishore, Katyayani Kumari
Pediatric brain tumors are the primary cause of death in children with cancer. Diffuse midline glioma (DMG) and diffuse intrinsic pontine glioma (DIPG) are frequently unresectable due to their difficult access location, and 5-year survival remains less than 20%. Despite significant advances in tumor biology and genetics, treatment options remain limited and ineffective. Immunotherapy using T cells with a chimeric antigen receptor (CAR) that has been genetically engineered is quickly emerging as a new treatment option for these patients...
April 26, 2024: Acta Neurologica Belgica
https://read.qxmd.com/read/38662121/infectious-complications-in-pediatric-patients-undergoing-cd19-cd22-chimeric-antigen-receptor-t-cell-therapy-for-relapsed-refractory-b-lymphoblastic-leukemia
#6
JOURNAL ARTICLE
Xiaochen Wu, Zhanmeng Cao, Zihan Chen, Yi Wang, Hailong He, Peifang Xiao, Shaoyan Hu, Jun Lu, Benshang Li
Chimeric antigen receptor T-cell (CAR-T) therapy is effective in the treatment of relapsed/refractory acute B-lymphoblastic leukemia (R/R B-ALL); however, patients who receive CAR-T therapy are predisposed to infections, with considerable detrimental effects on long-term survival rates and the quality of life of patients. This study retrospectively analyzed infectious complications in 79 pediatric patients with R/R B-ALL treated with CAR-T cells at our institution. Overall, 53 patients developed 88 infections...
April 25, 2024: Clinical and Experimental Medicine
https://read.qxmd.com/read/38660903/-impact-of-chaperone-mediated-autophagy-on-bilirubin-induced-damage-of-mouse-microglial-cells
#7
JOURNAL ARTICLE
Zhi-Fan Pan, Si-Yu Li, Ling Li, Yan Zhang, Zi-Yu Hua
OBJECTIVES: To investigate the effect of chaperone-mediated autophagy (CMA) on the damage of mouse microglial BV2 cells induce by unconjugated bilirubin (UCB). METHODS: The BV2 cell experiments were divided into two parts. (1) For the CMA activation experiment: control group (treated with an equal volume of dimethyl sulfoxide), QX77 group (treated with 20 μmol/L QX77 for 24 hours), UCB group (treated with 40 μmol/L UCB for 24 hours), and UCB+QX77 group (treated with both 20 μmol/L QX77 and 40 μmol/L UCB for 24 hours)...
April 15, 2024: Zhongguo Dang Dai Er Ke za Zhi, Chinese Journal of Contemporary Pediatrics
https://read.qxmd.com/read/38649631/plasma-neurological-biomarkers-as-a-measure-of-neurotoxicity-in-pediatric-dental-general-anesthesia-a-prospective-observational-feasibility-study
#8
JOURNAL ARTICLE
S Chakithandy, H Nazzal, M Matoug-Elwerfelli, S Narasimhan, S Uddin, K S Prabhu, L Zarif, N Mumtaz, A Sharma, M Al-Khelaifi
PURPOSE: Neurotoxicity concerns have been raised over general anesthesia and sedation medication use in children. Such concerns are largely based on animal studies, historical anesthetic agents, and assessment tools, thus warranting further investigations. Blood biomarkers in detecting neuronal inflammation and apoptosis are novel methods for detecting neuronal damage. Therefore, the aim of this feasibility study was to assess the usefulness of the levels of four plasma biomarkers in dental general anesthesia (DGA) as surrogate markers of neurotoxicity in children...
April 22, 2024: European Archives of Paediatric Dentistry: Official Journal of the European Academy of Paediatric Dentistry
https://read.qxmd.com/read/38642113/radiomic-%C3%A2-and-dosiomic-based-clustering-development-for-radio-induced-neurotoxicity-in-pediatric-medulloblastoma
#9
JOURNAL ARTICLE
Stefano Piffer, Daniela Greto, Leonardo Ubaldi, Marzia Mortilla, Antonio Ciccarone, Isacco Desideri, Lorenzo Genitori, Lorenzo Livi, Livia Marrazzo, Stefania Pallotta, Alessandra Retico, Iacopo Sardi, Cinzia Talamonti
BACKGROUND: Texture analysis extracts many quantitative image features, offering a valuable, cost-effective, and non-invasive approach for individual medicine. Furthermore, multimodal machine learning could have a large impact for precision medicine, as texture biomarkers can underlie tissue microstructure. This study aims to investigate imaging-based biomarkers of radio-induced neurotoxicity in pediatric patients with metastatic medulloblastoma, using radiomic and dosiomic analysis. METHODS: This single-center study retrospectively enrolled children diagnosed with metastatic medulloblastoma (MB) and treated with hyperfractionated craniospinal irradiation (CSI)...
April 20, 2024: Child's Nervous System: ChNS: Official Journal of the International Society for Pediatric Neurosurgery
https://read.qxmd.com/read/38613056/comparing-aluminum-concentrations-in-adult-and-pediatric-parenteral-nutrition-solutions-multichamber-bag-versus-compounded-parenteral-nutrition
#10
JOURNAL ARTICLE
David Berlana, Juan López-Hellín, Alba Pau-Parra, Roser Ferrer-Costa
Aluminum contamination in parenteral nutrition (PN) solutions can lead to neurotoxicity, reduced bone mass, and liver toxicity, especially in pediatric patients. Ingredients commonly used in PN compounding, such as vitamins, trace elements, calcium, and phosphate salts, contain significant amounts of aluminum. This study aimed to compare aluminum concentrations in multichamber-bag (MCB) and compounded PN for adults and pediatrics. A prospective study assessed aluminum concentrations in various types of MCB and compared them with compounded PN formulations with similar compositions...
April 1, 2024: Nutrients
https://read.qxmd.com/read/38601369/pediatric-anesthesia-exposure-decoding-its-neurodevelopmental-implications-and-navigating-the-nuances
#11
REVIEW
Wael AlKattan, Belal N Sabbah, Mohammad A Alghafees, Ahmad N Sabbah, Alanood Alsaleem, Meshari A Alqahtani, Alshaima Almadani, Aljazi Alrashid, Faris B Alshabanat, Mohammed S Ali Omar, Abderrahman Ouban, Mohamed Umair Aleem, Aladeen Barbour, Abdalrahman Abuzubida, Nadine A Osman, Saad S Ali, Zain Abbara, Mohammed A Alfuwais
General anesthesia is fundamental in pediatric medical interventions, but its potential neurodevelopmental impact on children has raised concerns, necessitating a thorough investigation. This systematic review aimed to assess the association between pediatric anesthesia exposure and neurodevelopmental outcomes, focusing on dosage effects and identifying high-risk groups. The study involved an extensive literature search across PubMed, Medline, and Google Scholar, selecting 40 relevant studies from an initial pool of 2,000, based on inclusion criteria that focused on children under 18 years exposed to anesthesia, excluding those with major comorbidities or perioperative physiological insults...
March 2024: Curēus
https://read.qxmd.com/read/38600717/impact-of-prophylactic-echinocandin-on-the-development-of-neurological-complications-in-patients-receiving-busulfan-containing-conditioning-regimens-for-stem-cell-transplantation-a-single-center-retrospective-study
#12
JOURNAL ARTICLE
Shogo Horikawa, Kenji Kishimoto, Suguru Uemura, Sayaka Hyodo, Aiko Kozaki, Atsuro Saito, Toshiaki Ishida, Takeshi Mori, Daiichiro Hasegawa, Yoshiyuki Kosaka
BACKGROUND: Although neurotoxicity is a major adverse event associated with busulfan, little information is available regarding the association between drug interactions and neurological symptoms during busulfan-based regimens. This study evaluated the association between prophylactic echinocandins and neurological complications in patients receiving busulfan-containing conditioning regimens for stem cell transplantation. METHODS: We retrospectively included consecutive patients who administered intravenous busulfan as a conditioning regimen at our facility between 2007 and 2022...
May 2024: Pediatric Transplantation
https://read.qxmd.com/read/38590373/characterization-of-brain-development-with-neuroimaging-in-a-female-mouse-model-of-chemotherapy-treatment-of-acute-lymphoblastic-leukemia
#13
JOURNAL ARTICLE
Kellen Gandy, Timothy R Koscik, Tyler Alexander, Jeffrey D Steinberg, Kevin R Krull, Ellen van der Plas
BACKGROUND: Survivors of pediatric acute lymphoblastic leukemia (ALL) exhibit abnormal neurocognitive outcomes that are possibly due to exposures to neurotoxic chemotherapy agents. This study aimed to determine the feasibility of characterizing long-term neuroanatomical changes with in vivo neuroimaging in a preclinical model of treatment for ALL. METHODS: Female mice (C57BL/6) were randomly assigned to a saline control group (n=10) or a treatment group (n=10) that received intrathecal methotrexate and oral dexamethasone (IT-MTX + DEX)...
March 27, 2024: Translational Pediatrics
https://read.qxmd.com/read/38586621/illuminating-progress-a-comprehensive-review-of-the-evolution-of-phototherapy-for-neonatal-hyperbilirubinemia
#14
REVIEW
Ankita Patel, Jayant D Vagha, Revat J Meshram, Amar Taksande, Rahul Khandelwal, Aditya Jain, Astha Khurana
This comprehensive review thoroughly examines the historical evolution, physiological foundations, and contemporary advancements in the application of phototherapy for neonatal hyperbilirubinemia. Neonatal hyperbilirubinemia, a common condition resulting from the immature hepatic processes in newborns, poses potential risks, including neurotoxicity, if left untreated. The review traces the historical progression from early recognition of neonatal jaundice to the development of various phototherapy modalities, showcasing the dynamic landscape of neonatal care...
March 2024: Curēus
https://read.qxmd.com/read/38586100/screening-of-potential-biomarkers-in-propofol-induced-neurotoxicity-via-bioinformatics-prediction-and-experimental-verification
#15
JOURNAL ARTICLE
Tianping He, Jianfeng Huang, Bo Peng, Mianhui Wang, Qiuhao Shui, Liang Cai
OBJECTIVES: To identify hub genes and biological processes of propofol-induced neurotoxicity and promote the development of pediatric anesthesiology. METHODS: We downloaded the GSE106799 dataset from the Gene Expression Omnibus database. Differentially expressed genes (DEGs) were screened, then Kyoto Encyclopedia of Genes and Genomes, Gene Ontology and Gene Set Enrichment analyses were performed on all DEGs. We identified potential ferroptosis genes in the pathogenesis of propofol-induced neurotoxicity...
2024: American Journal of Translational Research
https://read.qxmd.com/read/38575193/detecting-high-dose-methotrexate-induced-brain-changes-in-pediatric-and-young-adult-cancer-survivors-using-18-f-fdg-pet-mri-a-pilot-study
#16
JOURNAL ARTICLE
Lucia Baratto, Shashi B Singh, Sharon E Williams, Sheri L Spunt, Jarrett Rosenberg, Lisa Adams, Vidyani Suryadevara, Michael Iv, Heike Daldrup-Link
Significant improvements in treatments for children with cancer have resulted in a growing population of childhood cancer survivors who may face long-term adverse outcomes. Here, we aimed to diagnose high-dose methotrexate-induced brain injury on [18 F]FDG PET/MRI and correlate the results with cognitive impairment identified by neurocognitive testing in pediatric cancer survivors. Methods: In this prospective, single-center pilot study, 10 children and young adults with sarcoma ( n = 5), lymphoma ( n = 4), or leukemia ( n = 1) underwent dedicated brain [18 F]FDG PET/MRI and a 2-h expert neuropsychologic evaluation on the same day, including the Wechsler Abbreviated Scale of Intelligence, second edition, for intellectual functioning; Delis-Kaplan Executive Function System (DKEFS) for executive functioning; and Wide Range Assessment of Memory and Learning, second edition (WRAML), for verbal and visual memory...
April 4, 2024: Journal of Nuclear Medicine
https://read.qxmd.com/read/38539543/cumulative-dosage-of-intrathecal-chemotherapy-agents-predicts-white-matter-integrity-in-long-term-survivors-of-acute-lymphoblastic-leukemia-a-petale-study
#17
JOURNAL ARTICLE
Julie Laniel, Serge Sultan, Daniel Sinnett, Caroline Laverdière, Maja Krajinovic, Philippe Robaey, Luc Duong, Sarah Lippé
Acute lymphoblastic leukemia (ALL) stands as the most prevalent form of pediatric cancer in North America, with a current five-year survival rate of 85%. While more children achieved ALL remission and transition into adulthood, the prevalence of long-term treatment-related effects, especially neurocognitive sequelae, remains significant. This study pursues two objectives. Firstly, it investigates if Magnetization Transfer Ratio (MTR), a method assessing myelin integrity, is sensitive to white matter (WM) microstructural changes in long-term ALL survivors and whether these relate to cognitive impairments...
March 19, 2024: Cancers
https://read.qxmd.com/read/38507119/acute-kidney-injury-following-treatment-with-cd19-specific-car-t-cell-therapy-in-children-adolescent-and-young-adult-patients-with-b-cell-acute-lymphoblastic-leukemia
#18
JOURNAL ARTICLE
Yonique Petgrave, Subodh Selukar, Rebecca Epperly, Swati Naik, Noel DeLos Santos, Brandon M Triplett, Stephen Gottschalk, John Bissler, Aimee C Talleur
BACKGROUND: CD19-specific chimeric antigen receptor (CAR) T-cell therapy has shown promising disease responses in patients with high-risk B-cell malignancies. However, its use may be related to complications such as immune-mediated complications, infections, and end-organ dysfunction. The incidence of post-CAR T-cell therapy acute kidney injury (AKI) in the children, adolescent, and young adult (CAYA) patient population is largely unreported. METHODS: The objectives of this study were to determine the incidence of AKI in CAYA patients with high-risk B-cell malignancies treated with CD19-CAR T-cell therapy, evaluate potential risk factors for developing AKI, and determine patterns of kidney function recovery...
March 20, 2024: Pediatric Nephrology
https://read.qxmd.com/read/38491306/cd22-car-t-cells-demonstrate-high-response-rates-and-safety-in-pediatric-and-adult-b-all-phase-1b-results
#19
JOURNAL ARTICLE
Liora M Schultz, Nikeshan Jeyakumar, Anne Marijn Kramer, Bita Sahaf, Hrishi Srinagesh, Parveen Shiraz, Neha Agarwal, Mark Hamilton, Courtney Erickson, Ashley Jacobs, Jennifer Moon, Christina Baggott, Sally Arai, Sushma Bharadwaj, Laura J Johnston, Michaela Liedtke, Robert Lowsky, Everett Meyer, Robert Negrin, Andrew Rezvani, Judy Shizuru, Surbhi Sidana, Emily Egeler, Sharon Mavroukakis, Ramya Tunuguntla, Nikolaos Gkitsas-Long, Aidan Retherford, Annie Kathleen Brown, Anne-Louise Gramstrap-Petersen, Raquel Martin Ibañez, Steven A Feldman, David B Miklos, Crystal L Mackall, Kara L Davis, Matthew Frank, Sneha Ramakrishna, Lori Muffly
Chimeric antigen receptor (CAR) T cells targeting CD22 (CD22-CAR) provide a therapeutic option for patients with CD22+ malignancies with progression after CD19-directed therapies. Using on-site, automated, closed-loop manufacturing, we conducted parallel Phase 1b clinical trials investigating a humanized CD22-CAR with 41BB costimulatory domain in children and adults with heavily treated, relapsed/refractory (r/r) B-ALL. Of 19 patients enrolled, 18 had successful CD22-CAR manufacturing, and 16 patients were infused...
March 15, 2024: Leukemia
https://read.qxmd.com/read/38487474/effect-of-chronic-prenatal-exposure-to-the-food-additive-titanium-dioxide-e171-on-respiratory-activity-in-newborn-mice
#20
JOURNAL ARTICLE
Eloïse Colnot, Julie O'Reilly, Didier Morin
Nanoparticles (NPs) possess unique properties that make their use valuable in all industries. Titanium dioxide (TiO2 ) NPs are extensively used as a white pigment in food (labeled under the European number E171) and personal care products, which creates a significant potential for chronic consumer exposure. Concerns about the potential toxic effects of TiO2 NPs have arisen, particularly in vulnerable populations, including pregnant women and infants. Recently, human materno-fetal transfer of E171 was demonstrated, and simultaneously, we reported that chronic prenatal exposure to reference P25 TiO2 NPs was found to alter the developing respiratory neural networks...
2024: Frontiers in Pediatrics
keyword
keyword
15811
1
2
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.